Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Kempkensteffen, Carsten ^a   Fritzsche, Florian Rudolf ^b   Johannsen, Manfred ^a   Weikert, Steffen ^b   Hinz, Stefan ^a   Dietel, Manfred ^a   Riener, Marc Oliver ^b   Moch, Holger ^b   Jung, Klaus ^c   Krause, Hans ^a   Miller, Kurt ^a   Kristiansen, Glen ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Berlin Institute for Urologic Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS ASSOCIATED FACTOR 1; HSXIAPAF1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; TISSUE MICROARRAY; APOPTOSIS; BIOSYNTHESIS; CELL NUCLEUS; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION REGULATION; KIDNEY TUMOR; METABOLISM; METHODOLOGY; MULTIVARIATE ANALYSIS; PHYSIOLOGY;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL NUCLEUS; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 69349092336     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-276     Document Type: Article

References (42)

1. Jemal A Siegel R Ward E Hao Y Xu J Murray T Thun MJ Cancer statistics, 2008 CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010 18287387
2. Flanigan RC Mickisch G Sylvester R Tangen C Van Poppel H Crawford ED Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis J Urol 2004, 171(3):1071-1076. 10.1097/ 01.ju.0000110610.61545.ae 14767273
3. Cohen HT McGovern FJ Renal-cell carcinoma N Engl J Med 2005, 353(23):2477-2490. 10.1056/NEJMra043172 16339096
4. Motzer RJ Bander NH Nanus DM Renal-cell carcinoma N Engl J Med 1996, 335(12):865-875. 10.1056/NEJM199609193351207 8778606
5. Meyer HA Tolle A Jung M Fritzsche FR Haendler B Kristiansen I Gaspert A Johannsen M Jung K Kristiansen G Identification of Stanniocalcin 2 as Prognostic Marker in Renal Cell Carcinoma Eur Urol 2009, 55(3):669-678. 10.1016/j.eururo.2008.04.001 18450365
6. Lam JS Breda A Belldegrun AS Figlin RA Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma J Clin Oncol 2006, 24(35):5565-5575. 10.1200/JCO.2006.08.1794 17158542
7. Gutwein P Schramme A Sinke N Abdel-Bakky MS Voss B Obermuller N Doberstein K Koziolek M Fritzsche F Johannsen M et al.Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients Eur J Cancer 2009, 45(3):478-89. 10.1016/ j.ejca.2008.10.023 19070478
8. Fritzsche FR Oelrich B Johannsen M Kristiansen I Moch H Jung K Kristiansen G Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas Clin Cancer Res 2008, 14(21):7035-7042. 10.1158/1078-0432.CCR-08-0855 18981000
9. Reed JC Dysregulation of apoptosis in cancer J Clin Oncol 1999, 17(9):2941-2953. 10561374
10. Igney FH Krammer PH Death and anti-death: Tumour resistance to apoptosis Nat Rev Cancer 2002, 2(4):277-288. 10.1038/nrc776 12001989
11. Deveraux QL Reed JC IAP family proteins - suppressors of apoptosis Genes Dev 1999, 13(3):239-252. 10.1101/gad.13.3.239 9990849
12. Deveraux QL Stennicke HR Salvesen GS Reed JC Endogenous inhibitors of caspases J Clin Immunol 1999, 19(6):388-398. 10.1023/A:1020502800208 10634212
13. Deveraux QL Takahashi R Salvesen GS Reed JC X-linked IAP is a direct inhibitor of cell-death proteases Nature 1997, 388(6639):300-304. 10.1038/40901 9230442
14. LaCasse EC Baird S Korneluk RG MacKenzie AE The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 1998, 17(25):3247-3259. 10.1038/sj.onc.1202569 9916987
15. Verhagen AM Vaux DL Cell death regulation by the mammalian IAP antagonist Diablo/Smac Apoptosis 2002, 7(2):163-166. 10.1023/ A:1014318615955 11865200
16. Du C Fang M Li Y Li L Wang X Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 2000, 102(1):33-42. 10.1016/S0092-8674(00)00008-8 10929711
17. Fong WG Liston P Rajcan-Separovic E St Jean M Craig C Korneluk RG Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines Genomics 2000, 70(1):113-122. 10.1006/geno.2000.6364 11087668
18. Liston P Fong WG Kelly NL Toji S Miyazaki T Conte D Tamai K Craig CG McBurney MW Korneluk RG Identification of XAF1 as an antagonist of XIAP anti-Caspase activity Nat Cell Biol 2001, 3(2):128-133. 10.1038/35055027 11175744
19. Leaman DW Chawla-Sarkar M Vyas K Reheman M Tamai K Toji S Borden EC Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis J Biol Chem 2002, 277(32):28504-28511. 10.1074/jbc.M204851200 12029096
20. Arora V Cheung HH Plenchette S Micali OC Liston P Korneluk RG Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex J Biol Chem 2007, 282(36):26202-26209. 10.1074/ jbc.M700776200 17613533
21. Lee MG Huh JS Chung SK Lee JH Byun DS Ryu BK Kang MJ Chae KS Lee SJ Lee CH et al. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: Implication for attenuated p53 response to apoptotic stresses Oncogene 2006, 25(42):5807-5822. 10.1038/sj.onc.1209867 16909101
22. Xia Y Novak R Lewis J Duckett CS Phillips AC Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP Mol Cell Biochem 2006, 286(1-2):67-76. 10.1007/ s11010-005-9094-2 16432762
23. Tamm I Kornblau SM Segall H Krajewski S Welsh K Kitada S Scudiero DA Tudor G Qui YH Monks A et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias Clin Cancer Res 2000, 6(5):1796-1803. 10815900
24. Ramp U Krieg T Caliskan E Mahotka C Ebert T Willers R Gabbert HE Gerharz CD XIAP expression is an independent prognostic marker in clear-cell renal carcinomas Hum Pathol 2004, 35(8):1022-1028. 10.1016/ j.humpath.2004.03.011 15297970
25. Yan Y Mahotka C Heikaus S Shibata T Wethkamp N Liebmann J Suschek CV Guo Y Gabbert HE Gerharz CD Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas Br J Cancer 2004, 91(7):1349-1357. 10.1038/sj.bjc.6602127 15328523
26. Kempkensteffen C Hinz S Schrader M Christoph F Magheli A Krause H Schostak M Miller K Weikert S Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: Correlations with pathology and outcome Cancer Lett 2007, 254(2):227-235. 10.1016/ j.canlet.2007.03.006 17449173
27. Fritzsche FR Wassermann K Jung M Tolle A Kristiansen I Lein M Johannsen M Dietel M Jung K Kristiansen G ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression BMC Cancer 2008, 8:179. 2442841 18582378 10.1186/1471-2407-8-179
28. Ma TL Ni PH Zhong J Tan JH Qiao MM Jiang SH Low expression of XIAP-associated factor 1 in human colorectal cancers Chin J Dig Dis 2005, 6(1):10-14. 10.1111/j.1443-9573.2005.00180.x 15667552
29. Ng KC Campos EI Martinka M Li G XAF1 expression is significantly reduced in human melanoma J Invest Dermatol 2004, 123(6):1127-1134. 10.1111/ j.0022-202X.2004.23467.x 15610524
30. Byun DS Cho K Ryu BK Lee MG Kang MJ Kim HR Chi SG Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas Cancer Res 2003, 63(21):7068-7075. 14612497
31. Augello C Caruso L Maggioni M Donadon M Montorsi M Santambrogio R Torzilli G Vaira V Pellegrini C Roncalli M et al Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma BMC Cancer 2009, 9:25. 2680906 19397802 10.1186/ 1471-2407-9-125
32. Sakemi R Yano H Ogasawara S Akiba J Nakashima O Fukahori S Sata M Kojiro M X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues Oncol Rep 2007, 18(1):65-70. 17549347
33. Zhang F Wu LM Zhou L Chen QX Xie HY Feng XW Zheng SS Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation Ann Surg Oncol 2008, 15(12):3494-3502. 10.1245/s10434-008-0146-1 18830757
34. Shibata T Noguchi T Takeno S Gabbert HE Ramp U Kawahara K Disturbed XIAP and XAF1 Expression Balance Is an Independent Prognostic Factor in Gastric Adenocarcinomas Ann Surg Oncol 2008, 15(12):3579-87. 10.1245/ s10434-008-0062-4 18807090
35. Chung SK Lee MG Ryu BK Lee JH Han J Byun DS Chae KS Lee KY Jang JY Kim HJ et al. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses Gastroenterology 2007, 132(7):2459-2477. 10.1053/j.gastro.2007.04.024 17570219
36. Leaman DW Chawla-Sarkar M Jacobs B Vyas K Sun Y Ozdemir A Yi T Williams BR Borden EC Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: Greater potency of IFN-beta compared with IFN-alpha2 J Interferon Cytokine Res 2003, 23(12):745-756. 10.1089/ 107999003772084860 14769151
37. Reu FJ Bae SI Cherkassky L Leaman DW Lindner D Beaulieu N MacLeod AR Borden EC Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation J Clin Oncol 2006, 24(23):3771-3779. 10.1200/JCO.2005.03.4074 16801630
38. Motzer RJ Murphy BA Bacik J Schwartz LH Nanus DM Mariani T Loehrer P Wilding G Fairclough DL Cella D et al. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma J Clin Oncol 2000, 18(16):2972-2980. 10944130
39. Minasian LM Motzer RJ Gluck L Mazumdar M Vlamis V Krown SE Interferon alfa-2a in advanced renal cell carcinoma: Treatment Results and survival in 159 patients with long-term follow-up J Clin Oncol 1993, 11(7):1368-1375. 8315435
40. Escudier B Pluzanska A Koralewski P Ravaud A Bracarda S Szczylik C Chevreau C Filipek M Melichar B Bajetta E Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: A randomised, double-blind phase III trial Lancet 2007, 370(9605):2103-2111. 10.1016/ S0140-6736(07)61904-7 18156031
41. Pinho MB Costas F Sellos J Dienstmann R Andrade PB Herchenhorn D Peixoto FA Santos VO Small IA Guimaraes DP et al. XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy Urol Oncol 2009, 27(4):382-90. 18555708
42. Qi R Gu J Zhang Z Yang K Li B Fan J Wang C He Z Qiao L Lin Z et al. Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis Cancer Gene Ther 2007, 14(1):82-90. 10.1038/sj.cgt.7700992 17008933